Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
40.66
+1.52 (3.88%)
At close: Dec 20, 2024, 4:00 PM
40.90
+0.24 (0.59%)
After-hours: Dec 20, 2024, 7:54 PM EST
Kymera Therapeutics Stock Forecast
Stock Price Forecast
The 16 analysts with 12-month price forecasts for Kymera Therapeutics stock have an average target of 54, with a low estimate of 30 and a high estimate of 74. The average target predicts an increase of 32.81% from the current stock price of 40.66.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for KYMR stock from 16 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 4 | 5 |
| Buy | 3 | 4 | 5 | 5 | 6 | 7 |
| Hold | 6 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 11 | 12 | 12 | 14 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Initiates $60 | Strong Buy | Initiates | $60 | +47.57% | Dec 10, 2024 |
| BMO Capital | BMO Capital | Hold Initiates $55 | Hold | Initiates | $55 | +35.27% | Dec 6, 2024 |
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $38 → $57 | Hold → Buy | Upgrades | $38 → $57 | +40.19% | Dec 2, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $65 | Buy | Initiates | $65 | +59.86% | Nov 18, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $45 → $49 | Hold | Maintains | $45 → $49 | +20.51% | Nov 6, 2024 |
Financial Forecast
Revenue This Year
52.16M
from 78.59M
Decreased by -33.63%
Revenue Next Year
69.46M
from 52.16M
Increased by 33.16%
EPS This Year
-2.91
from -2.52
EPS Next Year
-3.11
from -2.91
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 78.8M | 171.2M | 171.2M | |||
| Avg | 52.2M | 69.5M | 61.2M | |||
| Low | 41.2M | 14.7M | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 0.2% | 228.1% | 146.4% | |||
| Avg | -33.6% | 33.2% | -12.0% | |||
| Low | -47.6% | -71.8% | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -2.24 | -1.58 | -2.14 | |||
| Avg | -2.91 | -3.11 | -3.55 | |||
| Low | -3.06 | -4.27 | -6.05 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.